#hVIVO

#HVO #hVIVO - Influenza HCT contract signed with Traws Pharma & launch of unified brand identity

-Contract win: hVIVO signs CTA with Traws Pharma to run influenza human challenge trial

-Now operating under one unified hVIVO brand

read: novuscomms.com/2026/04/14/h...

#HVO hVIVO PLC - Appointment of Independent Non-Executive Director - Novus Comms hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that further to its announcement on 12 May 2025, the Compan...

#HVO #hVIVO - Appointment of Independent Non-Executive Director

✅ hVIVO plc appoints Tracey James as Independent Non-Executive Director from 1 June 2025.

✅ She will chair the Audit Committee and join the Remuneration and Nominations Committees.

read: novuscomms.com/2025/05/29/h...

#HVO hVIVO PLC - Final Results - Novus Comms hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (“CRO”) and the world leader in human challenge clinical trials, announces its audited results for the year ended 31 December 2024. ...

#HVO #hVIVO - What a great set of final results

-Revenue up 11.9% to £62.7 million (2023: £56.0 million)

- EBITDA up 25.9% to £16.4 million (2023: £13.0 million)

-Cash of £44.2 million as at 31 December 2024 (31 December 2023: £37.0 million)

More here: novuscomms.com/2025/04/10/h...